ATOSSA THERAPEUTICS INC (ATOS:NASDAQ)
$2.49 0.1 (4.1841%)
Analysed ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) News Sources
ATOS: Initiating Coverage of Atossa Therapeutics; Endoxifen’s Expanding Opportunity from Oncology to Orphan Disease
13-05-2026
yahoo.com
Atossa Therapeutics to Host Virtual KOL Event Featuring Dr. Laura Esserman to Discuss Development of (Z)-Endoxifen in ER-Positive Breast Cancer
14-05-2026
yahoo.com
Atos Selected by Viasat to Modernize Global Digital Workplace Operations
19-05-2026
yahoo.com
Atossa Therapeutics Announces ASCO 2026 Abstracts Highlighting (Z)-Endoxifen Activity Across ESR1 Mutations and Ongoing EVANGELINE Phase 2 Trial
27-05-2026
yahoo.com
CEO Chat with Steven Quay, MD, PhD, Chairman, President, & CEO of Atossa Therapeutics
01-06-2026
yahoo.com
Atossa Therapeutics highlights Endoxifen progress as potential Breast Cancer treatment
10-06-2026
yahoo.com
Atossa Therapeutics Announces Registered Direct Offering of up to $16.5 Million in Gross Proceeds
11-06-2026
yahoo.com
Top Midday Decliners
11-06-2026
yahoo.com
Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds
12-06-2026
yahoo.com
ATOS: Raises up to $16.5 Million in Registered Direct Offering
01-07-2026
yahoo.com
What is the current price of ATOSSA THERAPEUTICS INC (ATOS:NASDAQ)?
The current price of ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) is $2.49.
ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) absolute price change since previous trading day?
The absolute price change of ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) since the previous trading day is $0.1.
ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) percentage price change since previous trading day?
The percentage price change of ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) since the previous trading day is 4.1841%.
What is the most recent average sentiment score for ATOSSA THERAPEUTICS INC (ATOS:NASDAQ)?
The most recent average sentiment score for ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for ATOSSA THERAPEUTICS INC (ATOS:NASDAQ)?
The most recent sentiment for ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) is .
SEC-8K** Filing Available For ATOSSA THERAPEUTICS INC (ATOS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.